Filter By Industry
Filter By Tag

Newsroom

DelveInsight Press releases

91 - 100 of 145 Press Releases

Gastroparesis-Pipeline Insights, 2015 - A DelveInsight’s Report
Oct 12, 2015
DelveInsight, the leading market research and consulting company has added a new report “Gastroparesis-Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight.

Constipation-Pipeline Insights, 2015 - A DelveInsight’s Report
Oct 12, 2015
DelveInsight, the leading market research and consulting company has added a new report “Constipation-Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight.

Proprotein Convertase Subtilisin/Kexin Inhibitors-Pipeline Insights, 2015–A DelveInsight’s Report
Oct 09, 2015
DelveInsight, the leading market research and consulting company has added a report “Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors -Pipeline Insights, 2015” to its portfolio.

Non Muscle Invasive Bladder Cancer (NMIBC) - Pipeline Insights, 2015 - A D
Oct 06, 2015
DelveInsight, the leading market research and consulting company has added a new report “NMIBC - Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline insight.

PCSK9 Inhibitors -Pipeline Insights, 2015” – A DelveInsight’s Report
Sep 22, 2015
DelveInsight, the leading market research and consulting company has added a new report “PCSK9 Inhibitors -Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on Mechanism of Action Pipeline Insight.

Short Bowel Syndrome-Pipeline Insights, 2015 – A DelveInsight’s Report
Sep 22, 2015
DelveInsight, the leading market research and consulting company has added a new report “Short Bowel Syndrome-Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on Indication Pipeline Insight.

“Fatty Acid Amide Hydrolase Inhibitors - Pipeline Insights, 2015”- A DelveInsight’s Report
Sep 18, 2015
DelveInsight, the leading market research and consulting company has added a new report “Fatty Acid Amide Hydrolase (FAAH) Inhibitors - Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on MoA

DelveInsight’s Orphan Indications Pipeline Reports
Sep 10, 2015
DelveInsight, the leading market research and consulting company serve as a Knowledge partner across the value chain of Pharmaceutical Industry. We made strong presence in Orphan market with 200+ Reports on Orphan based indications Pipeline Insights.

“Interstitial Cystitis - Pipeline Insights, 2015” – A DelveInsight’s Report
Sep 09, 2015
DelveInsight, the leading market research and consulting company has added a new report “Interstitial Cystitis (Painful Bladder Syndrome)-Pipeline Insights, 2015” to its portfolio.

“DNA Methyltransferase Inhibitors -Pipeline Insights, 2015” – A DelveInsight’s Report
Sep 07, 2015
DelveInsight, the leading market research and consulting company has added a new report “DNA Methyltransferase Inhibitors -Pipeline Insights, 2015” to its portfolio. With this launch DelveInsight now has 700+ Reports on MOA Pipeline in


Page: Prev 8 9 10 11 12 Next
DelveInsight RSS Feed